Radical surgery and reoperation in supratentorial malignant glial tumors

被引:36
作者
Daneyemez, M [1 ]
Gezen, F [1 ]
Çanakçi, Z [1 ]
Kahraman, S [1 ]
机构
[1] GATA Med Fac, Dept Neurosurg, Gulhane Med Sch, Ankara, Turkey
关键词
glial tumor; radical surgery; reoperation; survival;
D O I
10.1055/s-2008-1052044
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The treatment modalities for gliomas are still questioning and searching. We reviewed the effect of the extent of surgical resection and reoperation on the length and quality of survival in 152 consecutive patients who underwent operation for supratentorial gliomas at GATA Neurosurgery clinic between 1985 to 1995. Seventy-two patients (50%) had glioblastoma multiforme (GBM), and 48 patients (33%) had anaplastic astrocytoma (AA). Cross total resection was achieved in 70 cases (49%), subtotal resection was performed in 60 cases (42%), and biopsy was carried out in 14 cases (9%). Thirty-two patients were reoperated for recurrency and the median interval between the first operation and reoperation was 9.5 months in glioblastoma multiforme, and 11.7 months in anaplastic astrocytoma. The resection groups were compared for age, sex, preoperative and postoperative Karnofsky rating, tumor location, postoperative radiation therapy, and chemotherapy, and survival according to multivariate analysis. Preoperative Karnofsky rating and surgical resection type were the most important factors related to survival after operation or reoperation. The gross total resection group lived longer than the subtotal resection group by life table analysis. Median survival of GBM was 76 weeks in gross total resection group, and 33 months in AA group with total resection (p < 0.001). Preoperative Karnofsky scores had a statistically significant effect on the quality of life and survival after operation and reoperation in all cases (p=0.005). Radical surgery and reoperation also improve quality and length of life in selective malignant supratentorial gliomas.
引用
收藏
页码:209 / 213
页数:5
相关论文
共 37 条
[11]  
COUX DR, 1972, J R STAT SOC B, V34, P187
[12]  
DEVITA VT, 1983, CANCER, V51, P1209, DOI 10.1002/1097-0142(19830401)51:7<1209::AID-CNCR2820510707>3.0.CO
[13]  
2-J
[14]  
GREENE GM, 1989, J NEUROSURG, V71, P491
[15]  
GULLOTTA F, 1981, ADV TECHNICAL STANDA, V8, P123
[16]   REOPERATION FOR RECURRENT GLIOBLASTOMA AND ANAPLASTIC ASTROCYTOMA [J].
HARSH, GR ;
LEVIN, VA ;
GUTIN, PH ;
SEAGER, M ;
SILVER, P ;
WILSON, CB .
NEUROSURGERY, 1987, 21 (05) :615-621
[17]  
HILL CH, 1979, SPSS UPDATE NEW PROC, P36
[18]   ASSUMPTIONS IN THE RADIOTHERAPY OF GLIOBLASTOMA [J].
HOCHBERG, FH ;
PRUITT, A .
NEUROLOGY, 1980, 30 (09) :907-911
[19]   INVITRO KILLING OF HUMAN GLIOBLASTOMA BY INTERLEUKIN-2-ACTIVATED AUTOLOGOUS LYMPHOCYTES [J].
JACOBS, SK ;
WILSON, DJ ;
KORNBLITH, PL ;
GRIMM, EA .
JOURNAL OF NEUROSURGERY, 1986, 64 (01) :114-117
[20]  
JAMES CD, 1988, CANCER RES, V48, P5546